E-LIB Suche - Ergebnisse für: E. Loginova Yu

1

7 year of sacroiliac radiographic progression in early psor..:

E. Yu. Loginova ; P. O. Tremaskina ; E. E. Gubar...
https://rsp.mediar-press.net/rsp/article/view/3518/2353. , 2024

Link: https://rsp.mediar-press..

2

Results of a non-interventional observational multicenter s..:

T. V. Korotaeva ; E. E. Gubar ; E. Yu. Loginova...
https://mrj.ima-press.net/mrj/article/view/1498/1411. , 2023

Link: https://mrj.ima-press.ne..

3

Evaluation of the possibility of axial psoriatic arthritis ..:

E. E. Gubar ; T. V. Korotaeva ; Y. L. Korsakova...
https://rsp.mediar-press.net/rsp/article/view/3404/2309. , 2023

Link: https://rsp.mediar-press..

4

Factors associated with achieving an acceptable health-rela..:

P. O. Tremaskina ; T. V. Korotaeva ; E. Yu. Loginova...
https://mrj.ima-press.net/mrj/article/view/1499/1413. , 2023

Link: https://mrj.ima-press.ne..

5

Prognostic factors associated with non-remission and low di..:

E. Yu. Loginova ; T. V. Korotaeva ; E. E. Gubar...
https://rsp.mediar-press.net/rsp/article/view/3441/2320. , 2023

Link: https://rsp.mediar-press..

6

Search for predictors of achieving minimal disease activity..:

L. D. Vorobyova ; T. V. Korotaeva ; S. I. Glukhova...
https://mrj.ima-press.net/mrj/article/view/1500/1414. , 2023

Link: https://mrj.ima-press.ne..

7

Impact of tofacitinib on patient-reported outcomes in patie..:

L. D. Vorobyeva ; T. V. Korotaeva ; E. Yu. Loginova...
https://rsp.mediar-press.net/rsp/article/view/3181. , 2022

Link: https://doi.org/10.47360..

8

2-years outcomes of the treat-to-target strategy in early p..:

E. Yu. Loginova ; T. V. Korotaeva ; E. E. Gubar...
https://rsp.mediar-press.net/rsp/article/view/3226. , 2022

Link: https://doi.org/10.47360..

9

Impact of tofacitinib on patient-reported outcomes in patie..:

L. D. Vorobyeva ; T. V. Korotaeva ; E. Yu. Loginova...
https://rsp.mediar-press.net/rsp/article/view/3181/2195. , 2022

Link: https://rsp.mediar-press..

10

Clinical and instrumental characteristics of axial involvem..:

E. E. Gubar ; T. V. Korotaeva ; Yu. L. Korsakova...
https://rsp.mediar-press.net/rsp/article/view/3201/2215. , 2022

Link: https://rsp.mediar-press..

11

Validation of the PsAID-12 Russian questionnaire in patient..:

L. D. Vorobyeva ; E. Yu. Loginova ; Yu. L. Korsakova...
https://rsp.mediar-press.net/rsp/article/view/3152. , 2022

Link: https://doi.org/10.47360..

12

Janus kinase inhibitors in the treatment of psoriatic arthr..:

E. Yu. Loginova ; T. V. Korotaeva ; Е. Ю. Логинова.
https://mrj.ima-press.net/mrj/article/view/1245/1199. , 2022

Link: https://mrj.ima-press.ne..

13

Prognostic factors associated with achieving minimal diseas..:

E. Yu. Loginova ; T. V. Korotaeva ; E. E. Gubar.
https://rsp.mediar-press.net/rsp/article/view/3253. , 2022

Link: https://doi.org/10.47360..

14

2-years outcomes of the treat-to-target strategy in early p..:

E. Yu. Loginova ; T. V. Korotaeva ; E. E. Gubar...
https://rsp.mediar-press.net/rsp/article/view/3226/2230. , 2022

Link: https://rsp.mediar-press..

15

Janus kinase inhibitors in the treatment of psoriatic arthr..:

E. Yu. Loginova ; T. V. Korotaeva
https://mrj.ima-press.net/mrj/article/view/1245. , 2022

Link: https://doi.org/10.14412..